AstraZeneca PLC

AstraZeneca PLC is a leading biopharmaceutical company that focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. It has a proven, successful track record of more than 20 years, having developed products that have made a difference to millions of patients all around the world. Its marketed products, which include oncology, cardiovascular, renal, metabolism and respiratory and immunology medications, are sold in more than 100 countries worldwide.

The company is renowned for its ongoing commitment to research and development, and it has several strategic partnerships and collaborations with leading organizations such as Regeneron Pharmaceuticals, Inc., Neurimmune AG, Ionis Pharmaceuticals, Inc., Proteros Biostructures GmbH and Sierra Oncology, Inc. AstraZeneca even has its own clinical development organization which specializes in researching and developing the best treatments for a number of illnesses and conditions, including cancer, diabetes and cardiovascular diseases.

Additionally, AstraZeneca is the manufacturer of a number of vaccines including Vaxzevria, Evusheld and Fluenz Tetra/FluMist Quadrivalent for Influenza. In the wake of the Covid-19 pandemic, the company has been heavily involved in the development of a vaccine, and has already released AZD1222, which is being developed with the University of Oxford.

Furthering its commitment to global health, AstraZeneca has also joined forces to form AZ&Me, a global programme which provides access to AstraZeneca medications to eligible patients on low or fixed incomes.

AstraZeneca also has an impressive presence in the world of digital healthcare, partnering with leading technology companies to focus on the development of new products and digital health solutions, such as virtual reality, wearable medical devices, digital health coaching and artificial intelligence.

In 2019, the company earned over $23.3 billion in revenue and had more than 50,000 employees worldwide, making it one of the largest pharmaceutical companies in the world. The company is headquartered in Cambridge, UK, and has representative offices in the United Kingdom, Europe, the Americas, Africa, Asia and Australasia.